RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/β-catenin Signaling Pathway


如何引用文章

全文:

详细

Backgrounds:Gastric cancer (GC) is threatening public health, with at least one million new cases reported each year. Rhomboid domain-containing protein 1 (RHBDD1) has been identified to regulate the proliferation, migration, and metastasis of cancer cells. However, the role of RHBDD1 in GC has not been elucidated.

Objects:This study aimed to investigate the role of RHBDD1 on the growth, metastasis, and stemness characteristics of GC.

Methods:RHBDD1 expression was analyzed from the TCGA databank. qRT-PCR was conducted to evaluate the transcription level of RHBDD1. Western blots were used to evaluate the protein expression of RHBDD1, CD133, CD44, Nanog, β-catenin and c-myc. Colony formation assay and transwell assay were conducted to evaluate the growth and metastasis of NCI-N87 cells, respectively. Sphere-forming assay was performed to study the stemness characteristics. The nude mice xenotransplantation model and immunohistochemistry (IHC) were performed to evaluate the growth of GC in vivo.

Results:RHBDD1 expression is elevated in GC cells and clinical tissues. RHBDD1 expression is positively associated with cell proliferation and metastasis of GC cells. RHBDD1 knockdown suppresses the expression of CD133, CD44 and Nanog and attenuates sphere-forming ability. RHBDD1 activates the Wnt/β-catenin pathway via promoting the expression of β-catenin / c-myc and inducing β-catenin translocation into nuclear. RHBDD1 knockdown inhibits the growth of GC in nude mice xenotransplantation model.

Conclusion:RHBDD1 is highly expressed in GC, and its knockdown inhibits the growth, metastasis and stemness characteristics of GC cells through activating the Wnt/β-catenin pathway, suggesting that RHBDD1 has the potential to be a novel therapeutic target for GC treatment.

作者简介

Yingxue Yang

Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical

Email: info@benthamscience.net

Yuan Yuan

Department of Ultrasound, Chongqing Traditional Chinese Medicine Hospital

Email: info@benthamscience.net

Boning Xia

Department of Gastrointestinal Anorectal Surgery, The Second Affiliated Hospital of Chongqing Medical

编辑信件的主要联系方式.
Email: info@benthamscience.net

参考

  1. Zhu Z, Yu Z, Rong Z, et al. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42. Theranostics 2019; 9(26): 8294-311. doi: 10.7150/thno.36256 PMID: 31754397
  2. Huang T, Song X, Xu D, et al. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics 2020; 10(19): 8721-43. doi: 10.7150/thno.41648 PMID: 32754274
  3. Fu L, Bu L, Yasuda T, et al. Gastric cancer stem cells: Current insights into the immune microenvironment and therapeutic targets. Biomedicines 2020; 8(1): 7. doi: 10.3390/biomedicines8010007 PMID: 31935894
  4. Chen L, Yang QC, Li YC, et al. Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. Cancer Immunol Res 2020; 8(2): 179-91. doi: 10.1158/2326-6066.CIR-19-0394 PMID: 31771985
  5. Xu J, Qin N, Jiang W, Chen T. Amygdalin suppresses the proliferation, migration and EMT of gastric cancer cells by inhibiting TGF-β/Smad signal pathway. Trop J Pharm Res 2022; 21(4): 721-6. doi: 10.4314/tjpr.v21i4.6
  6. Xu S, Zhang H, Wang A, Ma Y, Gan Y, Li G. Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1. Cell Mol Biol Lett 2020; 25(1): 36. doi: 10.1186/s11658-020-00229-6 PMID: 32528541
  7. Zhao C, Ling X, Li X, Hou X, Zhao D. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1. Breast Cancer 2019; 26(6): 817-25. doi: 10.1007/s12282-019-00989-w PMID: 31243644
  8. Xu Z, Wang R, Li X, et al. RHBDD1 silencing inhibited cell growth and invasion of non-small cell lung cancer by mediating ZEB1/PI3K/AKT signaling pathway. J Mol Histol 2021; 52(3): 503-10. doi: 10.1007/s10735-020-09943-z PMID: 33515112
  9. Li M, Cai L, Wang X, et al. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway. Mol Med Rep 2021; 24(6): 826. doi: 10.3892/mmr.2021.12466 PMID: 34581421
  10. Zhang M, Miao F, Huang R, et al. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1. J Exp Clin Cancer Res 2018; 37(1): 1-14. doi: 10.1186/1756-9966-31-1 PMID: 29301578
  11. Wang T, Zhang X, Liu W, Sun C, Li Z, Zhao D. Prognostic and Immunological Significance of Rhomboid Domain Containing Protein 1 in Multiple Primary Cancers. Comb Chem High Throughput Screen 2022; ••• doi: 10.2174/1386207325666220609120001 PMID: 35692140
  12. Xia B, Zhang K, Liu C. PYGB promoted tumor progression by regulating Wnt/β-catenin pathway in gastric cancer. Technol Cancer Res Treat 2020; 19 doi: 10.1177/1533033820926592 PMID: 32462986
  13. Akrami H, Moradi B, Borzabadi Farahani D, Mehdizadeh K. Ibuprofen reduces cell proliferation through inhibiting Wnt/β catenin signaling pathway in gastric cancer stem cells. Cell Biol Int 2018; 42(8): 949-58. doi: 10.1002/cbin.10959 PMID: 29512256
  14. Yu J, Peng W, Xue Y, Li Y, Yang L, Geng Y. FUBP1 promotes the proliferation of lung squamous carcinoma cells and regulates tumor immunity through PD-L1. Allergol Immunopathol (Madr) 2022; 50(5): 68-74. doi: 10.15586/aei.v50i5.659 PMID: 36086966
  15. Zhang F, Guo J, Yu S, Zhao X, Ma Y, Yang D. Huwe1 inactivation promotes ovarian cancer metastasis by extracellular matrix deregulation. Eur J Gynaecol Oncol 2022; 43(1): 48-55. doi: 10.31083/j.ejgo4301013
  16. Chen L, Wang X, Zhu Y, Liu F, Liu L, Jiang N. Effects of miR-211-3p/RHBDD1 axis on cell proliferation, cell cycle progression, and epithelial-mesenchymal transition in glioma. Folia Neuropathol 2022; 60(2): 195-209. doi: 10.5114/fn.2022.118186 PMID: 35950472
  17. Jin X, Jin W, Li G, Zheng J. Zeaxanthin attenuates OVA-induced allergic asthma in mice by regulating the p38 MAPK/β-catenin signaling pathway. Allergol Immunopathol (Madr) 2022; 50(5): 75-83. doi: 10.15586/aei.v50i5.664 PMID: 36086967
  18. Wang H, Chen X, Yang B, Xia Z, Chen Q. MiR-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1/Wnt/β-catenin signaling pathway. Cancer Cell Int 2020; 20(1): 491. doi: 10.1186/s12935-020-01516-0 PMID: 33041671
  19. Takebe N, Miele L, Harris PJ, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin Oncol 2015; 12(8): 445-64. doi: 10.1038/nrclinonc.2015.61 PMID: 25850553

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bentham Science Publishers, 2024